Showing results (31-40 of 146) with videos related to

Sort By:
Pageof 15
Cancer Letters|January 23, 2017
Induction of neuroendocrine differentiation in castration resistant prostate cancer cells by adipocyte differentiation-related protein (ADRP) delivered by exosomesLi-Chiung Lin, Allen C Gao, Chih-Ho Lai, et al.
Biochemical and Biophysical Research Communications|June 5, 2007
LIGHT, a member of the TNF superfamily, activates Stat3 mediated by NIK pathwayNagalakshmi Nadiminty, Jae Yeon Chun, Yan Hu, et al.
The Prostate|May 3, 2002
Stat3 activation in prostatic carcinomasRajiv Dhir, Zuyao Ni, Wei Lou, et al.
Molecular Cancer Therapeutics|September 19, 2007
Selenium inhibition of survivin expression by preventing Sp1 binding to its promoterJae Yeon Chun, Yan Hu, Elaine Pinder, et al.
Molecular Cancer Therapeutics|June 10, 2015
NF-κB2/p52:c-Myc:hnRNPA1 Pathway Regulates Expression of Androgen Receptor Splice Variants and Enzalutamide Sensitivity in Prostate CancerNagalakshmi Nadiminty, Ramakumar Tummala, Chengfei Liu, et al.
The Prostate|June 4, 2004
Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathwaySoo Ok Lee, Wei Lou, Candace S Johnson, et al.
The Prostate|May 14, 2015
Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibitionChengfei Liu, Wei Lou, Cameron Armstrong, et al.
Cancer Research|January 20, 2004
Prostate specific antigen expression is down-regulated by selenium through disruption of androgen receptor signalingYan Dong, Soo Ok Lee, Haitao Zhang, et al.
Endocrine-Related Cancer|March 25, 2014
Upregulation of glucose metabolism by NF-κB2/p52 mediates enzalutamide resistance in castration-resistant prostate cancer cellsYuanyuan Cui, Nagalakshmi Nadiminty, Chengfei Liu, et al.
The Prostate|December 6, 2013
Inhibition of constitutively active Stat3 reverses enzalutamide resistance in LNCaP derivative prostate cancer cellsChengfei Liu, Yezi Zhu, Wei Lou, et al.
Pageof 15